2022
|
Invention
|
Peptide compositions capable of binding lanthionine synthetase c-like protein (lancl) and uses th... |
2021
|
Invention
|
Compositions for treating respiratory tract infection and uses thereof.
The present disclosure r... |
|
Invention
|
Compositions for treating respiratory tract infection and uses thereof. The present disclosure re... |
2020
|
Invention
|
Cyclic peptide receptor lanthionine synthetase c-like protein (lancl) and uses thereof.
The pres... |
|
Invention
|
Cyclic peptide receptor lanthionine synthetase c-like protein (lancl) and uses thereof. The prese... |
|
Invention
|
Peptides and uses thereof.
Disclosed herein are methods and compositions for treating or prevent... |
|
Invention
|
Peptides and uses thereof. Disclosed herein are methods and compositions for treating or preventi... |
|
Invention
|
Peptides and uses thereof.
The present disclosure relates to the use of C-terminal fragments of ... |
|
Invention
|
Peptides and uses thereof. The present disclosure relates to the use of C-terminal fragments of h... |
2019
|
Invention
|
Cyclic peptides and uses thereof. 2 is absent; and wherein the peptide of formula (I), or the pha... |
|
Invention
|
Cyclic peptides and uses thereof. The present disclosure is directed to a peptide of formula (I),... |
|
Invention
|
Peptides and uses thereof.
A method of treating neuropathic pain in a subject, the method compri... |
|
Invention
|
Human growth hormone-derived peptides, and non-human variants thereof, for treating neuropathic p... |
|
Invention
|
Peptides and uses thereof. A method of treating neuropathic pain in a subject, the method compris... |